LON:UDGUdg Healthcare Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Udg Healthcare PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 744 +2.00 (+0.27 %) (As of 06/2/2020 04:00 PM ET) Add Compare Share Today's Range 739Now: GBX 744▼ 752.5050-Day Range 592.50MA: GBX 641.44▼ 74252-Week Range 423.40Now: GBX 744▼ 846Volume579,893 shsAverage Volume981,360 shsMarket Capitalization£1.87 billionP/E Ratio20.84Dividend Yield2.17%BetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendInsider TradesHeadlines UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; and serialization solutions. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is based in Dublin, the Republic of Ireland.Read More Beat the Market (BTM) Rank™ 2.4 Analyst's Opinion Consensus RatingUdg Healthcare has received a consensus rating of Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 886.67, Udg Healthcare has a potential upside of 19.2% from its current price of GBX 744.Amount of Analyst CoverageUdg Healthcare has only been the subject of 4 research reports in the past 90 days. Previous Next 3.0 Community Rank Outperform VotesUdg Healthcare has received 508 “outperform” votes. (Add your “outperform” vote.)Underperform VotesUdg Healthcare has received 347 “underperform” votes. (Add your “underperform” vote.)Community SentimentUdg Healthcare has received 59.42% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Udg Healthcare and other stocks. Vote “Outperform” if you believe UDG will outperform the S&P 500 over the long term. Vote “Underperform” if you believe UDG will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 2.5 Dividend Strength Dividend LeadershipUdg Healthcare is a leading dividend payer. It pays a dividend yield of 2.17%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthUdg Healthcare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Udg Healthcare is 0.36 %. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Udg Healthcare insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Udg Healthcare are expected to decrease by -100.00% in the coming year, from GBX 52 to GBX 0 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Udg Healthcare is 20.84, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 15.73.Price to Earnings Ratio vs. SectorThe P/E ratio of Udg Healthcare is 20.84, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 25.56.Price to Book Value per Share RatioUdg Healthcare has a P/B Ratio of 1.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.4Community Rank: 3.0Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.71 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Medical Distribution Sub-IndustryN/A SectorMedical Current SymbolLON:UDG Previous Symbol CUSIPN/A CIKN/A Webwww.udghealthcare.com Phone+353-1-4689000Debt Debt-to-Equity Ratio35.85 Current Ratio1.60 Quick Ratio1.52Price-To-Earnings Trailing P/E Ratio20.84 Forward P/E Ratio14.31 P/E GrowthN/A Sales & Book Value Annual Sales£1.34 billion Price / Sales1.40 Cash FlowGBX 68.02 per share Price / Cash Flow10.94 Book ValueGBX 377.60 per share Price / Book1.97Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees8,700 Outstanding Shares250,832,992Market Cap£1.87 billion Next Earnings DateN/A OptionableNot Optionable LSE:UDG Rates by TradingView Receive UDG News and Ratings via Email Sign-up to receive the latest news and ratings for UDG and its competitors with MarketBeat's FREE daily newsletter. Udg Healthcare (LON:UDG) Frequently Asked Questions How has Udg Healthcare's stock been impacted by COVID-19 (Coronavirus)? Udg Healthcare's stock was trading at GBX 628.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, UDG stock has increased by 18.4% and is now trading at GBX 744. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Udg Healthcare? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Udg Healthcare in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Udg Healthcare. How often does Udg Healthcare pay dividends? What is the dividend yield for Udg Healthcare? Udg Healthcare announced a dividend on Tuesday, November 26th. Shareholders of record on Thursday, January 9th will be paid a dividend of GBX 0.12 per share on Wednesday, February 5th. This represents a yield of 1.28%. The ex-dividend date of this dividend is Thursday, January 9th. This is an increase from Udg Healthcare's previous dividend of GBX 0.04. The official announcement can be viewed at this link. View Udg Healthcare's dividend history. What price target have analysts set for UDG? 6 Wall Street analysts have issued 1-year target prices for Udg Healthcare's stock. Their forecasts range from GBX 730 to GBX 1,165. On average, they anticipate Udg Healthcare's share price to reach GBX 886.67 in the next year. This suggests a possible upside of 19.2% from the stock's current price. View analysts' price targets for Udg Healthcare. Has Udg Healthcare been receiving favorable news coverage? News headlines about UDG stock have been trending very negative this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Udg Healthcare earned a news impact score of -3.5 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutUdg Healthcare. Who are some of Udg Healthcare's key competitors? Some companies that are related to Udg Healthcare include EBOS Group (EBO), TSE:AND (AND), Paragon Care (PGC), KDA Group (KDA), Manitex Capital (MNX), Anhui Conch Cement (SHTDY), MCKESSON EUROPE/ADR (CAKFY) and Synergy CHC (SNYR). View all competitors. What other stocks do shareholders of Udg Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Udg Healthcare investors own include Carillion (CLLN), NBT Bancorp (NBTB), CRH (CRH), Standard Life Aberdeen (SL), Carclo (CAR), CBS (CBS), Greencore Group (GNC), Allergan (AGN), Aviva (AV) and AutoZone (AZO). Who are Udg Healthcare's key executives? Udg Healthcare's management team includes the following people: Mr. Brendan Patrick McAtamney, CEO & Exec. Director (Age 56)Mr. Nigel Clerkin, CFO & Exec. Director (Age 45)Keith Byrne, Head of Investor Relations, Strategy & Corp. CommunicationsEleanor Garvey, Group Head of Quality & ComplianceMr. Damien Moynagh, Gen. Counsel & Company Sec. What is Udg Healthcare's stock symbol? Udg Healthcare trades on the London Stock Exchange (LON) under the ticker symbol "UDG." How do I buy shares of Udg Healthcare? Shares of UDG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Udg Healthcare's stock price today? One share of UDG stock can currently be purchased for approximately GBX 744. How big of a company is Udg Healthcare? Udg Healthcare has a market capitalization of £1.87 billion and generates £1.34 billion in revenue each year. Udg Healthcare employs 8,700 workers across the globe. What is Udg Healthcare's official website? The official website for Udg Healthcare is www.udghealthcare.com. How can I contact Udg Healthcare? Udg Healthcare's mailing address is River Walk 20, DUBLIN,, Ireland. The company can be reached via phone at +353-1-4689000. This page was last updated on 6/2/2020 by MarketBeat.com Staff
